<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0163159.ref033">
 <label>33</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Eaton</surname>
   <given-names>JW</given-names>
  </name>, 
  <name>
   <surname>Menzies</surname>
   <given-names>NA</given-names>
  </name>, 
  <name>
   <surname>Stover</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Cambiano</surname>
   <given-names>V</given-names>
  </name>, 
  <name>
   <surname>Chindelevitch</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Cori</surname>
   <given-names>A</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models</article-title>. 
  <source>
   <italic toggle="yes">Lancet Glob Health</italic>
  </source>
  <year>2014</year>,
  <volume>2</volume>:
  <fpage>e23</fpage>â€“
  <lpage>34</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S2214-109X(13)70172-4</pub-id>
  <?supplied-pmid 25104632?>
  <pub-id pub-id-type="pmid">25104632</pub-id>
 </mixed-citation>
</ref>
